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 ABStrAct | The purpose of this systematic review was to evaluate published data and to update our current knowledge about the 
impact on dental development of childhood hematopoietic stem-cell transplantation (HSCT), as well as the late effects 
of preparative regimens, for the treatment of onco-hematological malignancies. A systematic literature research was 
conducted to assess articles published since January 1980 until the present day that fi tted the predetermined inclu-
sion/exclusion criteria. Data compilation was divided into qualitative and quantitative dental development disturban-
ces. Demographic records were also gathered. First and second premolars and second molars were signifi cantly more 
affected in HSCT children. There was a positive correlation between age at the time of anticancer therapy administra-
tion and qualitative and quantitative dental development disturbances. The association of total body or head and neck 
radiation mieloablative treatments was shown to enhance the magnitude of dental development disturbances. Dental 
development disturbances due to childhood HSCT are commonly seen in long-term survivors. The knowledge of these 
alterations may help improve dental care and elevate the quality of life of these patients. Further studies are needed to 
understand the long-term effects of dental development disturbances in this group of patients.
 deScrIPtorS |  Bone Marrow Transplantation; Hematopoietic Stem Cell Transplantation; Child; Drug Therapy; Radiotherapy.
 reSumo | Revisão sistemática dos efeitos tardios de distúrbios de desenvolvimento dentário em pacientes submetidos a transplan-
te de células-tronco hematopoiéticas durante a infância • O objetivo desta pesquisa foi revisar sistematicamente as publicações 
referentes aos efeitos tardios decorrentes das alterações do desenvolvimento dentário em pacientes submetidos ao transplante de célu-
las-tronco hematopoiéticas durante a infância. A pesquisa sistemática da literatura avaliou os artigos publicados desde janeiro de 1980 
até a presente data que se enquadraram nos critérios de inclusão/exclusão pré-determinados. A compilação dos dados foi dividida em 
distúrbios de desenvolvimento dentário qualitativos e quantitativos. Além disso, os registros demográfi cos foram contabilizados. Os 
primeiros e segundos pré-molares e os segundos molares foram os dentes signifi cativamente mais afetados nas crianças submetidas ao 
transplante de células-tronco hematopoiéticas. Houve uma correlação positiva entre a idade em que as terapias antineoplásicas foram 
administradas e os distúrbios de desenvolvimento dentário qualitativos e quantitativos. A associação do tratamento mieloablativo por 
meio de radioterapia total ou em região de cabeça e pescoço apresentou correlação positiva com os distúrbios de desenvolvimento den-
tário. Essas alterações podem ser comumente vistas em pacientes que conseguem sobreviver ao transplante de células-tronco hema-
topoiéticas durante a infância. O conhecimento dessas alterações pode ajudar a melhorar o atendimento odontológico e elevar a quali-
dade de vida desses pacientes. Mais estudos são necessários para entender os efeitos de longo prazo dos distúrbios de desenvolvimento 
dentário para esse grupo de pacientes.
 deScrItoreS |  Transplante de Médula Óssea; Transplante de Células-Tronco Hematopoéticas; Criança; Quimioterapia; Radioterapia.
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IntroductIon
The treatment of childhood onco-hematologi-
cal malignancies through hematopoietic stem-cell 
transplantation (HSCT) combined with surgery, 
multi-agent chemotherapy (CT) and/or radiother-
apy (RT) has been successfully employed in more 
than 30,000 patients per year worldwide with 
successful results.1,2 Currently, a 5-year survival 
rate for the most common hematologic neoplasia— 
acute lymphoblastic leukemia—has exceeded 80%. 
In some groups, this rate may achieve 95%.3,4
However, at least more than two-thirds of these 
children may present several long-term complica-
tions due to HSCT and its preparative regimen.5,6 
It is estimated that between 62% and 95% of the 
children surviving bone-marrow transplanta-
tion (BMT) will experience a late effect resulting 
from treatment and 27%–40% present serious 
consequences with elevated risk of death.7 The 
most commonly reported systemic complications 
involve the endocrine system, heart, lung, kid-
neys, bones and neurological structures, and may 
present as osteopenia, growth deficiency, changes 
in anatomical proportions, hypogonadism, pre-
mature menopause/andropause and disorders in 
the development of secondary sexual characteris-
tics.8-10
Dental development disturbances from HSCT 
have also been described and may involve tooth 
agenesis, microdontia, shortened roots, changes in 
tooth proportions (namely in the crown/root ratio), 
root stunting and V-shaped apex.11-15 Chemothera-
py-induced tooth formation anomalies have been 
reported to emerge mostly in the first and second 
premolars, and the second molar.15-17 These compli-
cations have been mostly associated with patients’ 
younger age at the time of transplantation but great 
controversy remains about: 
1. the real impact of radiation therapies, 
2. the extent of dental development disturbances 
and 
3. patients’ quality of life impairment due to these 
complications.18 
However, in spite of these relevant publications, 
a conclusive data compilation is still lacking about 
dentofacial development disturbances in long-term 
survivors of childhood HSCT. In this paper we 
present a systematic review of all articles published 
in English about the dentofacial abnormalities ob-
served in onco-hematologic children submitted 
to HSCT. The results include summarized demo-
graphic data about the patients, and the most com-
monly observed dental development disturbances 
findings in these long-term survivals.
methodology
Search strategies and criteria for  
selecting studies
We performed a systematic review of published 
manuscripts that discussed the dental develop-
ment disturbances and their subsequent late ef-
fects among survivors of HSCT for the treatment 
of childhood onco-hematological cancer, using the 
Pubmed and Google Scholar search engines. The 
following keyword combinations were employed in 
this review: 
• hematopoietic stem cell transplantation; 
• dental abnormalities; 
• children; 
• tooth development; 
• bone marrow transplantation; 
• dental development.
All of the article abstracts derived from this 
search were thoroughly reviewed for relevance. The 
inclusion criteria encompassed all of the full-arti-
cles published in the English language regarding 
the long-term dental follow-up of childhood-HSCT 
patients. The exclusion criteria comprised papers 
that failed to thoroughly present a comprehensive 
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abstracts and full-text articles, 105 papers were 
discarded for not matching the inclusion criteria. 
Ten papers fulfilled all of the previous established 
inclusion criteria and were considered in this re-
view. Six of them were cross-sectional studies, two 
were case-controls, one was a retrospective study 
and one was a cohort study (Figure 1). 
All together, the studies evaluated a total of 423 
patients with a mean age of 3 years (range: 4.7–25.9 
years). Patients’ median age at dental evaluation 
was 9 years, and, at HSCT, it was 3 years. Follow-up 
median time was 5 years. The most common onco-
hematological malignancy was acute lymphoblastic 
leukemia (ALL) comprising 45% of the diagnoses 
(n = 190), followed by acute myeloblastic leukemia 
(AML; 11%, n = 44), and neuroblastoma (NBL; 10%, 
n = 43). Other diagnoses comprised 45% of the 
study population (n = 144; Figure 2). 
Total body radiation therapy (TBR) was ad-
ministered to 25.9% (n = 88) of the patients with 
a mean dose of 11.5 Gy (range: 6–22 Gy), mainly 
for ALL treatment (76%; n = 72; Figures 3 and 4). 
When the authors provided a full description of 
the chemotherapeutic protocols involved, the most 
description of the chemo- and/or radiotherapy in-
volved; studies describing a follow-up period of less 
than 2 years; case reports or case-series; studies 
on adult-HSCT; and studies on HSCT for the treat-
ment of solid tumors or congenital diseases.
data collection
Two authors independently evaluated the meth-
odological quality of selected studies. Study quality 
was determined using four criteria: 
• comparability of subjects, 
• clear definition of exposure or intervention, 
• standard outcomes measurement and 
• appropriate statistical analysis. 
Any discrepancy in the validity assessment was 
resolved by discussion between authors. The rel-
evant data about sample size, age at diagnosis, type 
of diagnosis, follow-up period, type and details of 
treatment, late dental effects, and main endpoints 
from the selected studies were extracted by re-
searchers using a standardized form.
reSultS
data compilation
Our initial research retrieved a total of 117 titles 
and abstracts. After thorough examination of these 
Figure 1 | Paper selection algorithm. The keyword search re-
turned 117 papers. After thorough review, only 10 fulfilled the in-
clusion criteria. Of these, 6 were cross-sectional studies; 2 were 
case-control studies; 1 was a retrospective study and 1 was a co-
hort study.
Figure 2 | Descriptive diagnosis distribution. ALL: Acute lympho-
blastic leukemia; AML: Acute myeloblastic leukemia; NBL: Neuro-
blastoma; Other: other onco-hematological malignancies.
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common antineoplastic agent was a combination 
of cyclophosphamide (Cy) or busulfan (Bu) with 
vincristine (Vin) in association with methotrexate 
(MTX).
Qualitative comparisons of dental 
development disturbances 
A qualitative evaluation of dental developmen-
tal disturbances revealed that the most common-
ly described dental changes were root stunting, 
shortened or V-shaped roots, and premature api-
cal closure. The authors also extensively described 
dental agenesis and microdontia. These alterations 
were seen in a variable number of patients (33.3%–
100%), but most articles concluded that nearly all of 
the childhood cancer patients submitted to HSCT 
presented at least one dental development distur-
bance. The most affected teeth were the first and 
second premolars and the second molar, with the 
first molars or anterior teeth rarely being involved. 
A significant dental development disturbance was 
found in those patients submitted to radiation ther-
apy as a preparative regimen for HSCT (p = 0.01). 
The studies that presented statistical comparisons 
between different chemotherapeutic preparative 
regimens revealed poor statistical significance for 
differences in chemotherapeutic regimens. Age at 
HSCT was found to be more relevant in dental de-
velopment disturbances. 
Quantitative comparisons of dental 
development disturbances
The papers published more recently used pan-
oramic radiography to assess and compare dental 
developmental disturbances, and these evaluations 
involved performing tooth-area or crown-root (C:R) 
ratio measurements with imaging software and 
then performing statistical comparisons. The au-
thors quantitatively evaluated crown-root propor-
tion alterations and correlated them with adminis-
tered chemotherapeutic agents, focal or total body 
radiation therapy, age at HSCT and, in one study, 
alveolar bone growth and facial development.5 
The evaluation of tooth area or C:R propor-
tion revealed that nearly 80% (± 3.7) of the HSCT 
patients showed smaller teeth or C:R alterations 
with shortened roots. When tooth area or C:R pro-
portions of HSCT patients were compared with 
matched age and sex pairs, statistically significant 
Figure 4 | Total body irradiation (TBI) versus focal radiation 
therapy (non-TBI; %) column chart comparison. ALL: Acute lympho-
blastic leukemia; AML: Acute myeloblastic leukemia; NBL: Neuro-
blastoma; Other: other onco-hematological malignancies.
Figure 3 | Total body irradiation (TBI) versus focal radiation ther-
apy (non-TBI; %) disk chart distribution. ALL: Acute lymphoblastic 
leukemia; AML: Acute myeloblastic leukemia; Other: other onco-
hematological malignancies.
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differences were found (p = 0.002). In addition, the 
most affected teeth were the first and second pre-
molars and the second molars. 
correlation of age with dental development 
disturbances
There were strong correlations between age at 
HSCT and risk of developing dental disturbances. 
The patients that were submitted to HSCT before 
the age of 4 years showed a significantly higher 
prevalence of qualitative and quantitative devel-
opmental dental disturbances compared to nor-
mative data for first and second premolars in both 
the maxilla and mandible, as well as for second 
molars in the mandible (p < 0.001). In addition, 
the childhood cancer patients revealed to be at sig-
nificantly higher risk of presenting precocious api-
cal closure and advanced dental age in comparison 
with non-HSCT children with matched age and sex 
(p < 0.020). Childhood HSCT radiation therapy 
appeared to increase the risk of the occurrence of 
dental development disturbances, although, due to 
different preparative regimens, no statistical test 
could be performed to evaluate this risk increase. 
Different chemotherapeutic agents did not change 
the risk of developing dental developmental distur-
bances.
review considerations 
Our reviewers identified several faults in the 
published articles. First, not all of the studies pre-
sented detailed information about the chemothera-
peutic preparative regimens used, failing to fully 
describe the dosages and administration protocols 
of antineoplastic agents. In addition, poor descrip-
tions were found of the total body radiation thera-
py, whenever it was employed. Since we believe that 
dental development is a highly sensitive continuous 
process, detailed descriptions would seem to be im-
portant for identifying, preventing and managing 
the late effects of dental alterations induced by the 
chemo-radiotherapy administered for HSCT. The 
reviewers also identified an inaccurate description 
of the follow-up time among the published papers. 
This must be due to the difficulty involved in ac-
companying childhood-HSCT long-term survivors. 
Since the survival rates are continually rising, as 
is the number of patients likely to be included in 
study groups, we believe that this time issue will be 
surpassed as further investigations are conducted 
about the late systemic and local effects of HSCT.
conclusions and future directions
This systematic review summarizes the litera-
ture on the long-term effects of treatment-related 
dental development disturbances in survivors of 
childhood onco-hematological cancer. Only ten 
published papers fulfilled the inclusion/exclusion 
criteria and were evaluated for: 
• type of study, 
• number of individuals (n), 
• preparative regimen therapies, 
• qualitative and quantitative dental development 
disturbances, 
• follow-up time, and 
• age at HSCT. 
In addition, data on the purpose, results, and 
main conclusions were gathered. 
Data assembling suggested that a younger age at 
transplantation and preparative regimens seemed 
to be related to a higher risk of developing dental 
alterations, such as agenesis, dental hypoplasia, 
root stunting, crown-root proportion alterations, 
and microdontia. Additionally, total body radiation 
therapy and high-dose chemotherapy increased the 
risk of developing dental development disturbanc-
es in HSCT children. There was not sufficient evi-
dence to indicate that different chemotherapeutic 
mieloablative agents can have increased effects on 
dental development. 
There was a positive correlation between pa-
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tient age at HSCT and an increased risk of develop-
ing dental developmental disturbances. This find-
ing seems reasonable, since tooth formation is a 
continuous, highly sensitive and complex process 
led by several cytokines and an intricate interac-
tion between buccal epithelium and underlying ec-
tomesenchyme.19,20 Tooth development begins just 
after birth, lasts all childhood, and follows subse-
quential stages: 
• initiation stage, 
• bud stage, 
• cap stage, 
• bell stage, and finally 
• maturation.21 
These physiological processes occur at different 
moments of life, and any disturbance may interfere 
with tooth development. At the age of 4 years, a 
child has already formed the first molars and an-
terior teeth, while premolars and second molars 
are developing.22,23 This chronology may explain 
why these teeth showed the highest qualitative and 
quantitative dental alterations.
The limitations of the studies included in this 
systematic review should be considered. First, the 
cross-sectional observations of childhood can-
cer may have resulted in selection bias. It is pos-
sible that children with adverse dental outcomes 
were more likely to return for evaluation and care, 
which could have inflated report estimates. On the 
other hand, those patients who did not survive long 
enough to be included in the study groups may have 
biased the reported dental outcomes toward the 
null. Another study shortcoming was related to the 
small number of survivors, especially when there 
was no non-HSCT control group with matched age 
and sex, which may have compromised the data 
evaluation and led to non-reliable results. Fur-
thermore, some authors failed to present accurate 
descriptions of the chemical agents, radiation mie-
loablative therapy and preparative regimens used, 
whereas others failed to report specific information 
about the demographic characteristics of the study 
population and mean follow-up time.14,15,24 To offset 
this lack of data, further investigations are war-
ranted to provide more accurate information and 
help patients and dental care providers to improve 
the long-term quality of life of HSCT patients, fo-
cusing on the late effects involved. 
In conclusion, although HSCT has improved the 
survival rates of childhood cancer patients, this 
improvement has been accompanied by the occur-
rence of long-term treatment-related complications 
such as secondary neoplasms, organ dysfunction 
and psychosocial and cognitive disturbances25 
that may entail the perception of a poorer quality 
of life.18 The dental alterations induced by HSCT 
include aesthetic and functional impairment, and 
periodontal bone resorption, resulting in impair-
ment of chewing ability and a greater risk of early 
tooth loss, thus jeopardizing the long-term main-
tenance of oral health.24 In addition, it has been 
recently suggested that these dental complications 
could increase the cardiovascular morbidity and 
mortality rates associated with dental care inter-
vention among survivors. Further studies are re-
quired to outline the late dental effects of HSCT 
among survivors of childhood cancer treatment, 
contributing with new information about the exten-
sion of dental alterations, and with useful evidence 
to help predict the location of enamel defects. This 
information would help the dental team to provide 
improved dental care for these children and more 
accurate information to patients and parents on the 
possible long-term sequelae they might experience.
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